Hims & Hers Health (NYSE:HIMS) Stock Rating Lowered by TD Cowen
TD Cowen downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday morning, MarketBeat Ratings reports. They currently have $30.00 target price on the stock, down from their previous target price of $44.00. Several other brokerages have also […]
